Cited by 74

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Ultra-Processed Food Intake Is Associated with Non-Alcoholic Fatty Liver Disease in Adults: A Systematic Review and Meta-Analysis

Henney, Alex E., Gillespie, Conor S., Alam, Uazman, Hydes, Theresa J., Cuthbertson, Daniel J.·2023·Nutrients

Abstract

Non-alcoholic fatty liver disease (NAFLD) is associated with overweight/obesity, metabolic syndrome and type 2 diabetes (T2D) due to chronic caloric excess and physical inactivity. Previous meta-analyses have confirmed associations between ultra-processed food (UPF) intake and obesity and T2D. We aim to ascertain the contribution of UPF consumption to the risk of developing NAFLD. We performed a systematic review and meta-analysis (PROSPERO (CRD42022368763)). All records registered on Ovid Medline and Web of Science were searched from inception until December 2022. Studies that assessed UPF consumption in adults, determined according to the NOVA food classification system, and that reported NAFLD determined by surrogate (steatosis) scores, imaging or liver biopsy were included. The association between UPF consumption and NAFLD was assessed using random-effects meta-analysis methods. Study quality was assessed, and evidence credibility evaluated, using the Newcastle Ottawa Scale and NutriGrade systems, respectively. A total of 5454 records were screened, and 112 records underwent full text review. From these, 9 studies (3 cross-sectional, 3 case-control and 3 cohort), analysing 60,961 individuals, were included in the current review. Both moderate (vs. low) (pooled relative risk 1.03 (1.00–1.07) (p = 0.04) (I2 = 0%)) and high (vs. low) (1.42 (1.16–1.75) (<0.01) (I2 = 89%)) intake of UPF significantly increased the risk of NAFLD. Funnel plots demonstrate low risk of publication bias. Consumption of UPF is associated with NAFLD with a dose–response effect. Public health measures to reduce overconsumption of UPF are imperative to reduce the burden of NAFLD, and the related conditions, obesity and T2D.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu15102266

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. Chalasani, 2012, The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 55, 2005, 10.1002/hep.25762 · DOI
  2. Mantovani, 2021, Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: An updated meta-analysis of 501 022 adult individuals, Gut, 70, 962, 10.1136/gutjnl-2020-322572 · DOI · Paper page
  3. Lu, 2018, The relationship between obesity and the severity of non-alcoholic fatty liver disease: Systematic review and meta-analysis, Expert. Rev. Gastroenterol. Hepatol., 12, 491, 10.1080/17474124.2018.1460202 · DOI
  4. Cuthbertson, 2021, Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD), Ann. Med., 53, 1256, 10.1080/07853890.2021.1956685 · DOI
  5. Mantovani, 2018, Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis, Diabetes Care, 41, 372, 10.2337/dc17-1902 · DOI
  6. Utzschneider, 2006, The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease, J. Clin. Endocrinol. Metab., 91, 4753, 10.1210/jc.2006-0587 · DOI
  7. Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 · DOI · Paper page
  8. Estes, 2018, Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease, Hepatology, 67, 123, 10.1002/hep.29466 · DOI
  9. Monteiro, 2013, Ultra-processed products are becoming dominant in the global food system, Obes. Rev., 14, 21, 10.1111/obr.12107 · DOI · Paper page
  10. Newton, S., Braithwaite, D., and Akinyemiju, T.F. (2017). Socio-economic status over the life course and obesity: Systematic review and meta-analysis. PLoS ONE, 12. · DOI
  11. Moubarac, 2014, Food Classification Systems Based on Food Processing: Significance and Implications for Policies and Actions: A Systematic Literature Review and Assessment, Curr. Obes. Rep., 3, 256, 10.1007/s13679-014-0092-0 · DOI · Paper page
  12. Askari, 2020, Ultra-processed food and the risk of overweight and obesity: A systematic review and meta-analysis of observational studies, Int. J. Obes., 44, 2080, 10.1038/s41366-020-00650-z · DOI
  13. Delpino, 2022, Ultra-processed food and risk of type 2 diabetes: A systematic review and meta-analysis of longitudinal studies, Int. J. Epidemiol., 51, 1120, 10.1093/ije/dyab247 · DOI
  14. Chen, 2020, Consumption of ultra-processed foods and health outcomes: A systematic review of epidemiological studies, Nutr. J., 19, 86, 10.1186/s12937-020-00604-1 · DOI
  15. Lane, 2021, Ultraprocessed food and chronic noncommunicable diseases: A systematic review and meta-analysis of 43 observational studies, Obes. Rev., 22, e13146, 10.1111/obr.13146 · DOI · Paper page
  16. Zinöcker, M.K., and Lindseth, I.A. (2018). The Western Diet-Microbiome-Host Interaction and Its Role in Metabolic Disease. Nutrients, 10. · DOI · Paper page
  17. Webb, 2021, Ultra-processed food is associated with features of metabolic syndrome and non-alcoholic fatty liver disease, Liver Int., 41, 2635, 10.1111/liv.14996 · DOI
  18. Konieczna, J., Fiol, M., Colom, A., Martínez-González, M.Á., Salas-Salvadó, J., Corella, D., Soria-Florido, M.T., Martínez, J.A., Alonso-Gómez, Á.M., and Wärnberg, J. (2022). Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome. Nutrients, 14. · DOI
  19. Kullberg, 2022, Intake of Ultra-Processed Food and Ectopic-, Visceral- and Other Fat Depots: A Cross-Sectional Study, Front. Nutr., 9, 774718, 10.3389/fnut.2022.774718 · DOI
  20. Stang, 2010, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur. J. Epidemiol., 25, 603, 10.1007/s10654-010-9491-z · DOI · Paper page
  21. Schwingshackl, 2016, Perspective: NutriGrade: A Scoring System to Assess and Judge the Meta-Evidence of Randomized Controlled Trials and Cohort Studies in Nutrition Research, Adv. Nutr., 7, 994, 10.3945/an.116.013052 · DOI · Paper page
  22. Lachin, 2013, Power of the Mantel-Haenszel and other tests for discrete or grouped time-to-event data under a chained binomial model, Stat. Med., 32, 220, 10.1002/sim.5480 · DOI
  23. Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat. Med., 21, 1539, 10.1002/sim.1186 · DOI · Paper page
  24. Jackson, 2017, Paule-Mandel estimators for network meta-analysis with random inconsistency effects, Res. Synth. Methods, 8, 416, 10.1002/jrsm.1244 · DOI
  25. Odegaard, 2022, Levels of abdominal adipose tissue and metabolic-associated fatty liver disease (MAFLD) in middle age according to average fast-food intake over the preceding 25 years: The CARDIA Study, Am. J. Clin. Nutr., 116, 255, 10.1093/ajcn/nqac079 · DOI
  26. Yari, Z., Cheraghpour, M., Aghamohammadi, V., Alipour, M., Ghanei, N., and Hekmatdoost, A. (2020). Energy-dense nutrient-poor snacks and risk of non-alcoholic fattyliver disease: A case–control study in Iran. BMC Res. Notes, 13. · DOI
  27. Maroofi, 2022, Red and Processed Meat Intake in Relation to Non-Alcoholic Fatty Liver Disease Risk: Results from a Case-Control Study, Clin. Nutr. Res., 11, 42, 10.7762/cnr.2022.11.1.42 · DOI
  28. Martins, 2015, Ultra-processed foods and the nutritional dietary profile in Brazil, Rev. Saude Publica, 49, 38
  29. Fan, 2018, Association between body mass index and fatty liver risk: A dose-response analysis, Sci. Rep., 8, 15273, 10.1038/s41598-018-33419-6 · DOI
  30. Romieu, 2017, Energy balance and obesity: What are the main drivers?, Cancer Causes Control, 28, 247, 10.1007/s10552-017-0869-z · DOI
  31. Tsompanaki, E., Thanapirom, K., Papatheodoridi, M., Parikh, P., Chotai de Lima, Y., and Tsochatzis, E.A. (Clin. Gastroenterol. Hepatol., 2021). Systematic Review and Meta-analysis: The Role of Diet in the Development of Nonalcoholic Fatty Liver Disease, Clin. Gastroenterol. Hepatol., in press. · DOI
  32. Benini, 1995, Gastric emptying of a solid meal is accelerated by the removal of dietary fibre naturally present in food, Gut, 36, 825, 10.1136/gut.36.6.825 · DOI
  33. Schulte, E.M., Avena, N.M., and Gearhardt, A.N. (2015). Which foods may be addictive? The roles of processing, fat content, and glycemic load. PLoS ONE, 10. · DOI
  34. Hydes, 2021, The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?, Front. Nutr., 8, 640557, 10.3389/fnut.2021.640557 · DOI
  35. Cuthbertson, 2017, What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?, Int. J. Obes., 41, 853, 10.1038/ijo.2017.4 · DOI
  36. Walhin, 2021, Physiological responses to carbohydrate overfeeding, Curr. Opin. Clin. Nutr. Metab. Care, 24, 379, 10.1097/MCO.0000000000000755 · DOI
  37. Pérez-Montes de Oca, A., Julián, M.T., Ramos, A., Puig-Domingo, M., and Alonso, N. (2020). Microbiota, Fiber, and NAFLD: Is There Any Connection?. Nutrients, 12. · DOI
  38. Herman, 2016, The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis, Trends Endocrinol. Metab., 27, 719, 10.1016/j.tem.2016.06.005 · DOI
  39. Jensen, 2018, Fructose and sugar: A major mediator of non-alcoholic fatty liver disease, J. Hepatol., 68, 1063, 10.1016/j.jhep.2018.01.019 · DOI
  40. Eweis, 2017, Carbon dioxide in carbonated beverages induces ghrelin release and increased food consumption in male rats: Implications on the onset of obesity, Obes. Res. Clin. Pract., 11, 534, 10.1016/j.orcp.2017.02.001 · DOI
  41. Safarpour, 2022, Sodium in relation with nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies, Food Sci. Nutr., 10, 1579, 10.1002/fsn3.2781 · DOI
  42. Tong, 2009, Nitrosamine exposure causes insulin resistance diseases: Relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer’s disease, J. Alzheimers Dis., 17, 827
  43. Collison, 2009, Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease, J. Lipid Res., 50, 1521, 10.1194/jlr.M800418-JLR200 · DOI
  44. Emamat, 2020, Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism, EXCLI J., 19, 620
  45. Nettleton, 2009, Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA), Diabetes Care, 32, 688, 10.2337/dc08-1799 · DOI
  46. Payne, 2012, Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: Implications for host-microbe interactions contributing to obesity, Obes. Rev., 13, 799, 10.1111/j.1467-789X.2012.01009.x · DOI
  47. Dallio, M., Diano, N., Masarone, M., Gravina, A.G., Patanè, V., Romeo, M., Di Sarno, R., Errico, S., Nicolucci, C., and Abenavoli, L. (2019). Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease. Int. J. Environ. Res. Public Health, 16. · DOI
  48. Hwang, S., Lim, J.E., Choi, Y., and Jee, S.H. (2018). Bisphenol A exposure and type 2 diabetes mellitus risk: A meta-analysis. BMC Endocr. Disord., 18. · DOI
  49. Hou, 2022, Relationship Between Carbohydrate Intake (Quantity, Quality, and Time Eaten) and Mortality (Total, Cardiovascular, and Diabetes): Assessment of 2003–2014 National Health and Nutrition Examination Survey Participants, Diabetes Care, 45, 3024, 10.2337/dc22-0462 · DOI
  50. Caro, 2017, Designing a food tax to impact food-related non-communicable diseases: The case of Chile, Food Policy, 71, 86, 10.1016/j.foodpol.2017.08.001 · DOI
  51. Popkin, 2021, Towards unified and impactful policies to reduce ultra-processed food consumption and promote healthier eating, Lancet Diabetes Endocrinol., 9, 462, 10.1016/S2213-8587(21)00078-4 · DOI
  52. Colchero, 2016, Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: Observational study, BMJ, 352, h6704, 10.1136/bmj.h6704 · DOI
  53. Colchero, 2017, In Mexico, Evidence Of Sustained Consumer Response Two Years After Implementing A Sugar-Sweetened Beverage Tax, Health Aff., 36, 564, 10.1377/hlthaff.2016.1231 · DOI · Paper page
  54. Aranceta, 2015, Food frequency questionnaires, Nutr. Hosp., 31, 49
  55. Duvnjak, 2009, [Ultrasonography in the diagnosis of nonalcoholic fatty liver disease], Acta Med. Croatica, 63, 1

Cited by

Sorted by citations

Metadata

Authors
Henney, A. E., Gillespie, C. S., Alam, U., Hydes, T. J., & Cuthbertson, D. J.
Affiliations
  • Department of Cardiovascular & Metabolic Medicine, University of Liverpool, Liverpool L3 5TR, UK
  • Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 1TN, UK
Venue
Nutrients
Publisher
MDPI AG
Published
2023-05-10
Volume
15
Issue
10
Pages
2266
ISSN
2072-6643
Cited by
74
References
15
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review